WO 2018/220390
VATISH M., Sargent I., ZHANG W., kandzija N., Tannetta D.
The application discloses the following biomarkers for GDM (gestational diabetes mellitus): a. higher plasma level of insulin receptor (lR) expression on syncytiotrophoblast extracellular vesicles (STBEV) was observed in the GDM pregnancies compared to normal pregnancy (example of application p. 1 3 ll. 1 4-17). b. higher plasma levels of STBEV expressing Dipeptidyr peptidase rV (DPPIV) were observed in GDM pregnancies compared to normal pregnancies.